Summit Therapeutics PLC (ADR) (NASDAQ:SMMT): Alex Snow’s Lansdowne Partners filed an amended 13D.
You can check out Lansdowne Partners’ latest holdings and filings here.
Please follow Lansdowne Partners (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Lansdowne Partners or update its stock holdings.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|Lansdowne Partners (UK) L||0||19,060,500||0||19,060,500||19,060,500||27.11%|
|Lansdowne Developed Markets Master Fund Limited||0||19,060,500||0||19,060,500||19,060,500||27.11%|
Page 1 of 8 – SEC Filing
|SECURITIES AND EXCHANGE COMMISSION|
|Washington, D.C. 20549|
|Amendment No. 2|
|INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (a) AND |
AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (a)
|Summit Therapeutics PLC|
|(Name of Issuer)|
|American Depositary Shares and Ordinary Shares, par value £0.01 per share|
|(Title of Class of Securities)|
|c/o Lansdowne Partners (UK) LLP|
|15 Davies Street|
London W1K 3AG
|(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)|
|September 19, 2017|
|(Date of Event Which Requires Filing of this Statement)|
If the filing
person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D/A, and
is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box o.
filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for
other parties to whom copies are to be sent.
* The remainder
of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of
securities and for any subsequent amendment containing information which would alter disclosures provided in the cover page.
required on the remainder of this cover page shall not be deemed to be “filed” for the purposes of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).